Seres Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MCRB and other ETFs, options, and stocks.About MCRB
Seres Therapeutics, Inc. engages in the development of biological drugs through microbiome therapeutics platform. Its product pipeline includes SER-109, SER-287, SER-301, and SER-401.
CEOThomas J. DesRosier
CEOThomas J. DesRosier
Employees103
Employees103
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2010
Founded2010
Employees103
Employees103
MCRB Key Statistics
Market cap161.93M
Market cap161.93M
Price-Earnings ratio28.73
Price-Earnings ratio28.73
Dividend yield—
Dividend yield—
Average volume325.74K
Average volume325.74K
High today$17.90
High today$17.90
Low today$16.80
Low today$16.80
Open price$17.50
Open price$17.50
Volume101.24K
Volume101.24K
52 Week high$29.98
52 Week high$29.98
52 Week low$6.53
52 Week low$6.53
Stock Snapshot
As of today, Seres Therapeutics(MCRB) shares are valued at $17.90. The company's market cap stands at 161.93M, with a P/E ratio of 28.73.
As of 2025-12-05, Seres Therapeutics(MCRB) stock has fluctuated between $16.80 and $17.90. The current price stands at $17.90, placing the stock +6.5% above today's low and 0.0% off the high.
Seres Therapeutics(MCRB) shares are trading with a volume of 101.24K, against a daily average of 325.74K.
During the past year, Seres Therapeutics(MCRB) stock moved between $6.53 at its lowest and $29.98 at its peak.
During the past year, Seres Therapeutics(MCRB) stock moved between $6.53 at its lowest and $29.98 at its peak.
People also own
Based on the portfolios of people who own MCRB. This list is generated using Robinhood data, and it’s not a recommendation.